BURNEY CO/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
BURNEY CO/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37,800
-16.3%
35,0000.0%0.00%0.0%
Q2 2023$45,150
-2.3%
35,0000.0%0.00%0.0%
Q1 2023$46,200
-12.0%
35,0000.0%0.00%
-33.3%
Q4 2022$52,500
+28.0%
35,0000.0%0.00%
+50.0%
Q3 2022$41,000
+13.9%
35,000
+9.4%
0.00%0.0%
Q2 2022$36,000
-62.5%
32,0000.0%0.00%
-50.0%
Q1 2022$96,000
+12.9%
32,0000.0%0.00%0.0%
Q4 2021$85,000
-26.7%
32,0000.0%0.00%
-20.0%
Q3 2021$116,000
-16.5%
32,0000.0%0.01%
-16.7%
Q2 2021$139,000
+27.5%
32,0000.0%0.01%
+20.0%
Q1 2021$109,000
-2.7%
32,0000.0%0.01%
-16.7%
Q4 2020$112,000
+45.5%
32,0000.0%0.01%
+20.0%
Q3 2020$77,000
+30.5%
32,0000.0%0.01%
+25.0%
Q2 2020$59,000
+18.0%
32,0000.0%0.00%0.0%
Q1 2020$50,000
-26.5%
32,0000.0%0.00%0.0%
Q4 2019$68,000
-4.2%
32,000
+28.0%
0.00%0.0%
Q2 2018$71,000
-26.8%
25,0000.0%0.00%
-20.0%
Q4 2017$97,00025,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 9,105,691$30,140,0005.99%
Sio Capital Management, LLC 1,888,181$6,250,0003.50%
DAFNA Capital Management LLC 473,478$1,567,0001.32%
Cormorant Asset Management, LP 2,000,000$6,620,0000.96%
Ghost Tree Capital, LLC 1,100,000$3,641,0000.68%
Rhenman & Partners Asset Management AB 1,282,000$4,243,0000.67%
Palo Alto Investors LP 4,254,623$14,083,0000.67%
NEA Management Company, LLC 3,243,150$10,375,0000.36%
Telemetry Investments, L.L.C. 170,000$563,0000.25%
NJ State Employees Deferred Compensation Plan 355,000$1,175,0000.22%
View complete list of RIGEL PHARMACEUTICALS INC shareholders